Scotland · NHS Scotland MSAN
Buprenorphine (Reletrans®) 5micrograms/hour and 15micrograms/hour
MSAN(2025)24 · Level 2 · issued 16 May 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Sevodyne®) remain available and can support increased demand. | Available | — |
| patch that is available including: Bunov®, Butec®, BuTrans®, Rebrikel® and Sevodyne® (see | Available | — |
| moderate intensity when an opioid is necessary for obtaining adequate analgesia. They are available as | Available | — |
| 6. Buprenorphine patches are available as 72-hourly, 96-hourly and 7-day formulations. The BNF contains | Available | — |
| are available in strengths of 5, 10, 15 and 20 micrograms/hour as 7-day formulations. Prescribers and | Available | — |
| Registration for access to the website is available to UK healthcare professionals and organisations | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.